Literature DB >> 21646631

ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion.

G Sorarù1, M Clementi, M Forzan, V Orsetti, C D'Ascenzo, G Querin, A Palmieri, M Ermani, C Angelini, E Pegoraro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21646631     DOI： 10.1212/WNL.0b013e31821e557a

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  13 in total

1.  Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.

Authors:  Sirinan Tazen; Karla Figueroa; Justin Y Kwan; Jill Goldman; Ann Hunt; Jacinda Sampson; Laurie Gutmann; Stefan M Pulst; Hiroshi Mitsumoto; Sheng-Han Kuo
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.

Authors:  Marka van Blitterswijk; Bianca Mullen; Michael G Heckman; Matthew C Baker; Mariely DeJesus-Hernandez; Patricia H Brown; Melissa E Murray; Ging-Yuek R Hsiung; Heather Stewart; Anna M Karydas; Elizabeth Finger; Andrew Kertesz; Eileen H Bigio; Sandra Weintraub; Marsel Mesulam; Kimmo J Hatanpaa; Charles L White; Manuela Neumann; Michael J Strong; Thomas G Beach; Zbigniew K Wszolek; Carol Lippa; Richard Caselli; Leonard Petrucelli; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; Ian R Mackenzie; William W Seeley; Lea T Grinberg; Bruce L Miller; Kevin B Boylan; Neill R Graff-Radford; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers
Journal:  Neurobiol Aging       Date:  2014-05-02       Impact factor: 4.673

4.  Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.

Authors:  Hiroya Naruse; Takashi Matsukawa; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Hiroki Takano; Jun Goto; Tatsushi Toda; Shoji Tsuji
Journal:  Neurogenetics       Date:  2019-03-07       Impact factor: 2.660

5.  ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.

Authors:  Michael P Hart; Aaron D Gitler
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

6.  Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.

Authors:  Michael P Hart; Johannes Brettschneider; Virginia M Y Lee; John Q Trojanowski; Aaron D Gitler
Journal:  Acta Neuropathol       Date:  2012-04-21       Impact factor: 17.088

7.  Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.

Authors:  Serena Lattante; Stéphanie Millecamps; Giovanni Stevanin; Sophie Rivaud-Péchoux; Carine Moigneu; Agnès Camuzat; Sandra Da Barroca; Emeline Mundwiller; Philippe Couarch; François Salachas; Didier Hannequin; Vincent Meininger; Florence Pasquier; Danielle Seilhean; Philippe Couratier; Véronique Danel-Brunaud; Anne-Marie Bonnet; Christine Tranchant; Eric LeGuern; Alexis Brice; Isabelle Le Ber; Edor Kabashi
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

8.  ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population.

Authors:  Suna Lahut; Özgür Ömür; Özgün Uyan; Zeynep Sena Ağım; Aslihan Özoğuz; Yeşim Parman; Feza Deymeer; Piraye Oflazer; Filiz Koç; Hilmi Özçelik; Georg Auburger; A Nazlı Başak
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

9.  De novo mutations in ataxin-2 gene and ALS risk.

Authors:  José Miguel Laffita-Mesa; Jorge Michel Rodríguez Pupo; Raciel Moreno Sera; Yaimee Vázquez Mojena; Vivian Kourí; Leonides Laguna-Salvia; Michael Martínez-Godales; José A Valdevila Figueira; Peter O Bauer; Roberto Rodríguez-Labrada; Yanetza González Zaldívar; Martin Paucar; Per Svenningsson; Luís Velázquez Pérez
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

10.  Ataxin-2 modulates the levels of Grb2 and SRC but not ras signaling.

Authors:  Jessica Drost; David Nonis; Florian Eich; Oliver Leske; Ewa Damrath; Ewout R Brunt; Isabel Lastres-Becker; Rolf Heumann; Joachim Nowock; Georg Auburger
Journal:  J Mol Neurosci       Date:  2013-01-19       Impact factor: 3.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.